Skip to main content
logo
Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
13.66
+0.62 (4.75%)
At close: Mar 31, 2026

Telix Pharmaceuticals Revenue

In the year 2025, Telix Pharmaceuticals had annual revenue of $803.79M USD with 55.61% growth. Telix Pharmaceuticals had revenue of $413.44M in the half year ending December 31, 2025, with 122.47% growth.

Revenue
$803.79M
Revenue Growth
+66.17%
P/S Ratio
3.84
Revenue / Employee
$678.88K
Employees
1,184
Market Cap
4.63B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025803.79M287.24M55.61%
Dec 31, 2024516.55M183.57M55.13%
Dec 31, 2023332.98M224.03M205.64%
Dec 31, 2022108.95M103.42M1,873.24%
Dec 31, 20215.52M1.51M37.53%
Dec 31, 20204.01M1.57M64.21%
Dec 31, 20192.44M2.31M1,680.88%
Dec 31, 2018137.28K--
Dec 31, 2017---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.10B
Mesoblast98.02M
Clinuvel Pharmaceuticals96.30M
Neuren Pharmaceuticals64.65M
PYC Therapeutics20.56M
Starpharma Holdings14.58M
Clarity Pharmaceuticals10.58M
Orthocell9.33M
Revenue Rankings

Telix Pharmaceuticals News

More News